Latest Innovation News

BetMakers Technology Group capped FY25 with its strongest quarterly results ever, showcasing record profitability, positive cash flow, and a debt-free balance sheet. The company’s strategic investments and recent capital raise set the stage for accelerated growth in FY26, including a key acquisition in Nevada.

Kula Gold reports exceptional high-grade gold intercepts up to 83.6g/t from recent drilling at its Mt Palmer project, reinforcing the asset’s promising development potential.

Linius Technologies has landed a paid Proof of Concept with a leading European soccer league, aiming to showcase its video search and assembly platform to boost fan engagement. This deal could open doors to significant Tier 1 contracts in the lucrative European football market.

Genesis Energy reported a robust FY25 Q4, marking strategic milestones including a non-binding agreement to extend Rankine unit operations to 2035 and the start of Huntly BESS construction, while expanding customer flexibility programs.

Audinate Group has completed its $28 million acquisition of Iris Studio, a US-based leader in AI-powered, cloud-based camera control technology, marking a significant expansion into video production solutions.

Papyrus Australia has fully impaired its investments in its Egyptian joint ventures PPYEg and EBFC, citing lack of returns and governance issues ahead of its 2025 audited results.

Bio-Gene Technology Limited has completed the second tranche of its share placement, securing approximately A$2.46 million and issuing unlisted options to investors and its lead manager.

InteliCare Holdings announces CEO Daniel Pilbrow’s resignation effective October 2025, with Non-Executive Director Tim Chapman stepping in as interim executive director during the leadership transition.

AML3D has secured a AU$1.2 million order from Austal USA for a portable ARCEMY Small additive manufacturing system, set to enhance the US Navy’s manufacturing capabilities with rapid deployment and flexible use.

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

AnteoTech has signed a binding Term Sheet with US-based Black Diamond Structures to jointly develop and commercialise an advanced battery additive combining their proprietary technologies, targeting improved lithium-ion battery anodes with higher silicon content.

PainChek has completed its final FDA submission for the PainChek Adult App, targeting the US long-term care market with a potential $100 million annual opportunity. A regulatory decision is expected within 75 days, setting the stage for rapid commercialisation.